Feature | June 10, 2014

Real-Time Radiation Monitoring Reduces Patient, Cardiologist Exposure

RadiCure study evaluates device that beeps upon radiation exposure

June 10, 2014 — A real-time monitoring device that beeps in the presence of high doses of radiation can help reduce patient and interventional cardiologist exposure to radiation during cardiac catheterization, according to results of the RadiCure study presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2014 scientific sessions in Las Vegas.

Radiation exposure during cardiac catheterization can place both the patient and the physician at risk. Advances in imaging equipment have helped reduce patient exposure, but physician exposure is typically only measured months later. In the study presented at SCAI, researchers monitored physician and patient radiation exposure using a real-time, personal radiation monitoring device called the Bleeper Sv. The device sounds every 15 minutes in response to normal background radiation and increases its beep rate as radiation exposure increases.

For the study, 505 patients undergoing left cardiac catheterization procedures were randomized to use or not use the monitoring device. Procedure times and patient characteristics were comparable in both study groups. Following the procedure, patient and interventional cardiologist radiation exposure was measured.

Researchers found that compared to the control group, use of the monitoring device led to a significant decrease in operator exposure [0.9 (0.4-1.7) vs 1.4 (0.6-2.5) mrem, p<0.001 for the first operator and 0.5 (0.2-1.0) vs 0.7 (0.4-1.4) mrem, p<0.001 for the second operator]. Patient radiation exposure did not differ significantly between the two groups; however, there was a trend for lower Air Kerma and Dose Area Product radiation in the Bleeper Sv group [0.855 (0.58-1.507) vs 0.989 (0.610-1.802) Gray, p=0.153 and 76.68 (52.98-133.53) vs 84.61 (55.37-161.20) Gray*cm2, p=0.125, respectively].

“Use of a personal radiation monitoring device that provides auditory feedback helps reduce both the patient and the interventional cardiologist’s exposure,” said Georgios Christopoulos, M.D., research fellow at VA North Texas Health Care System and the University of Texas Southwestern Medical Center.

“The device allows for immediate reaction that can limit exposure, unlike current monitoring that physicians undergo months after exposure,” said Emmanouil Brilakis, M.D., Ph.D., FSCAI, director of the cardiac catheterization laboratories at VA North Texas Health Care System, associate professor of medicine at the University of Texas Southwestern Medical Center and the study’s principal investigator.

For more information: www.scai.org

Related Content

Intact Vascular, TOBA clinical study, one-year results, Tack Endovascular System, Journal of Vascular Surgery
News | Peripheral Arterial Disease (PAD)| August 24, 2016
Intact Vascular Inc. announced that the one-year results from its Tack Optimized Balloon Angioplasty (TOBA) clinical...
Technavio report, renal denervation devices, 2015
News | Renal Denervation| August 23, 2016
August 23, 2016 — Technavio analysts forecast the global...
Jason Burdick, injectable hydrogels, heart failure, heart attack, American Chemical Society

Compared to other types of hydrogels being developed (left), a new hydrogel (right) can form crosslinks after injection into the heart, making the material stiffer and longer-lasting. Image courtesy of American Chemical Society.

News | Heart Failure| August 23, 2016
August 23, 2016 — During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells within
News | Peripheral Arterial Disease (PAD)| August 22, 2016
Avinger Inc. recently announced the closing of its previously announced public offering of 9,857,800 shares of Avinger’...
DMC Heart Hospital, Detroit Medical Center, complex percutaneous intervention education course, PCI, cath lab training
News | Cath Lab| August 22, 2016
The Detroit Medical Center (DMC) Heart Hospital recently completed a Complex Percutaneous Intervention education course...
atomic bombs, radiation exposure, long-term health effects, Bertrand Jordan, study
News | Radiation Dose Management| August 19, 2016
The detonation of atomic bombs over the Japanese cities of Hiroshima and Nagasaki in August 1945 resulted in horrific...
TAILOR-PCI study, antiplatelet medication, genotype, NHLBI grant
News | Antiplatelet and Anticoagulation Therapies| August 18, 2016
Researchers at the Peter Munk Cardiac Centre, Toronto, and at Mayo Clinic are leading the Tailored Antiplatelet Therapy...
Covidien, Medtronic, TurboHawk, Atherectomy system

The Medtronic TurboHawk atherectomy system. 

Feature | Atherectomy Devices| August 18, 2016 | Dave Fornell
Due to poor outcomes from percutaneous transluminal angioplasty (PTA) ballooning of vessels alone, or of stenting in
Sapien III, Sapien 3, PARTNER III, FDA approval, expanded indication, intermediate risk patients

The Sapien 3 valve has a skirt of fabric at its base that has significantly reduced issues of paravalvular leak, which was an issue with the first generation Sapien device. 

Feature | Heart Valve Technology| August 18, 2016 | Dave Fornell
August 18, 2016 — The U.S.
Corindus Corpath, Acist Medical RXi and CVi, Fairview Southdale Hospital, Minnesota, cath lab
News | Cath Lab| August 17, 2016
Corindus Vascular Robotics Inc. and Acist Medical Systems Inc. are providing Fairview Southdale Hospital, Edina, Minn...
Overlay Init